Association of Serum γ-Glutamyltransferase With C-Reactive Protein Levels in Patients With Coronary Heart Disease

Yuanyuan He1, Mengnan Huang1, Zhu Li1

  • 1Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Angiology
|September 6, 2022
PubMed

Insights

Serum gamma-glutamyltransferase (GGT) levels are linked to C-reactive protein (CRP) in coronary heart disease (CHD) patients. Higher GGT levels significantly correlate with elevated CRP, suggesting GGT as a potential inflammatory marker for cardiovascular risk assessment.

Area of Science:

  • Cardiology
  • Biochemistry
  • Inflammation Research

Background:

  • Serum gamma-glutamyltransferase (GGT) and C-reactive protein (CRP) are established biomarkers.
  • Limited research exists on the GGT-CRP relationship specifically within coronary heart disease (CHD) populations.
  • Inflammation plays a critical role in the pathogenesis of CHD.

Purpose of the Study:

  • To investigate the association between serum GGT levels and CRP levels in a large cohort of patients with established CHD.
  • To determine if GGT can serve as an indicator of inflammation and cardiovascular risk in CHD patients.

Main Methods:

  • Retrospective analysis of 17,523 CHD patients who underwent GGT and CRP testing.
  • Patients categorized into three groups based on GGT tertiles.
  • Logistic regression analysis employed to assess the association between GGT and CRP, adjusting for relevant parameters.

Main Results:

  • A significant positive association was observed between serum GGT and CRP levels in CHD patients.
  • Patients in the highest GGT tertile (T3) had a significantly higher odds ratio (OR) for elevated CRP compared to the lowest tertile (T1) (OR: 2.15).
  • The association between GGT and CRP was pronounced in males compared to females.

Conclusions:

  • Serum GGT levels are significantly associated with CRP levels in patients with coronary heart disease.
  • GGT may function as a valuable inflammatory marker in CHD.
  • Elevated GGT could represent an additional tool for assessing cardiovascular risk in this patient group.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
195
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
46
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
108
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
290
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
38